Home
MSK Trials
MSK Centers
Screener
Search
Help
(888) 828-2206
Email Us
Menu
Home
MSK Trials
MSK Centers
Screener
(888) 828-2206
Email Us
Moffitt Cancer Center
Magnolia Campus
Tampa, FL
Website
(888) 828-2206
Refer Patient
Filters
Save & Share
Clear Filters
Diagnosis
Leukemia
Lymphoma
Myeloma
Myeloproliferative Neoplasms (MPN)
View All Trials
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Acute Promyelocytic Leukemia (APL)
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
Chronic Myeloid Leukemia (CML)
Chronic Myelomonocytic Leukemia (CMML)
Clonal Cytopenia of Undetermined Significance (CCUS)
Hairy Cell Leukemia (HCL)
Large Granular Lymphocytic Leukemia (LGL)
Mixed Phenotype Acute Leukemia (MPAL)
Myelodysplastic Syndromes
Prolymphocytic Leukemia (PLL)
Classifications
All Trials
ABL Kinase Inhibitor
AXL Inhibitor
Allogeneic Stem Cell Transplant
Antibody Drug Conjugate (ADC)
BCL-2 Inhibitor
BCL6 Degrader
BCR-ABL1 Tyrosine Kinase Inhibitor
BRD4 Inhibitor
BTK Degrader
BTK Inhibitor
Bispecific Antibody
CAR T Cell
CDC7 Inhibitor
CLK Inhibitor
CTPS1
Chemotherapy
Cyclin-Dependent Kinase Inhibitor (CDK Inhibitor)
Hypomethylating Agents (HMA)
IDH1 Inhibitor
IDH2 Inhibitor
JAK1 Inhibitor
JAK2 Inhibitor
Kinase Inhibitor
MALT1 Inhibitor
MCL-1 Inhibitor
MYB mRNA Degrader
Menin Inhibitor
Monoclonal Antibody
NLRP3 Inhibitor
T Cell (Allogeneic)
Trispecific Antibody
Tyrosine Kinase (TK) Inhibitor
Explore trials based on treatment classification/type.
MSK Service
Select
All Trials
Leukemia Service
Lymphoma Service
Myeloma Service
Transplant Service
Cell Therapy Service
Filter trials based on MSK Service
Genetics
Select
ZRSR2
U2AF1
TP53
TET2
SRSF2
SF3B1
RUNX1-RUNX1T1
NUP98r
NPM1
KMT2Ar
IDH2
IDH1
FLT3
DMNT3A
D835
CBFB-MYH11
BTK Mutation
BCR-ABL1
ASXL1
When selected, this filter returns all trials with inclusion or exclusion criteria that apply to the specific genetics.
Show All Filters
Patient Screener
Sorting
0
by
Sort by
Relevancy
No Results
No results were found that match your applied filters.